Astral Ltd

NSE: ASTRAL BSE: 532830

₹1368

(8.00%)

Tue, 07 Jul 2026, 10:49 am

MTF 5xInvest in Astral Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)39929.47

PE Ratio68.48

Dividend0.25

Producer Manufacturing

Miscellaneous Manufacturing

24.5K

Astral News

Astral board orders review of merger scheme

Astral Limited's board approved an independent review of its Composite Scheme of Arrangement following stakeholder feedback. A Big Four advisor will evaluate the scheme within 30 days.

06 Jul 2026

companies

Astral Demerger Draws Mixed Views from Brokerages

CLSA holds Astral at ₹1,475, JPMorgan downgrades to Neutral, and Investec maintains Buy at ₹1,710 amid chemicals business demerger plans.

29 Jun 2026

investment-ideas

Astral Ltd to host investor call on June 27

Astral Limited will hold an investor conference call with Investec Capital Services on June 27, 2026. Senior management will participate, and no price-sensitive information will be disclosed.

27 Jun 2026

companies

Astral approves demerger of chemicals business

Astral board approved a composite scheme to demerge its chemicals business into Astral Chemie and amalgamate Al-Aziz Plastics. Shareholders will receive shares in a 1:1 ratio.

25 Jun 2026

companies

Astral Subsidiary Acquires 60% Stake in DSS LLP for ₹39.11 Crore

Astral's subsidiary acquires a 60% stake in DSS LLP for ₹39.11 crore, marking a strategic expansion of its chemicals operations.

11 Jun 2026

companies

Showing 1–5 of 43

Rows per page:

Market Current News

SEBI Approves Rentomojo Ltd's IPO

SEBI has granted approval for Rentomojo Ltd's Initial Public Offering, marking a key regulatory milestone for the company's planned market debut.

06 Jul 2026

ipo

Concord Biotech Limited

Concord Biotech to hold 41st AGM on July 31

Concord Biotech Limited has scheduled its 41st Annual General Meeting for July 31, 2026, via video conferencing. The company has received a notice proposing the appointment of Mrs. Ekta Gupta as a Director.

06 Jul 2026

ipo

GUJARAT KIDNEY AND SUPER SPECI

Gujarat Kidney approves IPO proceeds variation

Shareholders approved the variation in the objects and terms of utilisation of the IPO proceeds. The resolution received 99.9995% votes in favour.

06 Jul 2026

ipo

SEBI Approves Manipal Health Enterprises IPO

SEBI has granted approval for Manipal Health Enterprises to proceed with its initial public offering, marking a significant milestone for the healthcare company.

06 Jul 2026

ipo

NSE Seeks RBI Nod for Quanto Cross Currency Derivatives

NSE has requested RBI approval to introduce Quanto Cross Currency Derivatives, aiming to boost exchange-traded currency volumes in India.

06 Jul 2026

currency

Showing 1–5 of 93967

Rows per page: